David Krause

2.3k total citations
39 papers, 1.7k citations indexed

About

David Krause is a scholar working on Epidemiology, Infectious Diseases and Hepatology. According to data from OpenAlex, David Krause has authored 39 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 11 papers in Infectious Diseases and 9 papers in Hepatology. Recurrent topics in David Krause's work include Hepatitis Viruses Studies and Epidemiology (9 papers), Hepatitis B Virus Studies (9 papers) and Viral gastroenteritis research and epidemiology (5 papers). David Krause is often cited by papers focused on Hepatitis Viruses Studies and Epidemiology (9 papers), Hepatitis B Virus Studies (9 papers) and Viral gastroenteritis research and epidemiology (5 papers). David Krause collaborates with scholars based in United States, Germany and Netherlands. David Krause's co-authors include James A. Dowell, Martin Stogniew, James P. Gilligan, Bharat Damle, Brian J. McMahon, Timothy Henkel, Tim Henkel, William Knebel, Žilvinas Endzinas and Dainis Krieviņš and has published in prestigious journals such as Hepatology, PEDIATRICS and Clinical Infectious Diseases.

In The Last Decade

David Krause

35 papers receiving 1.6k citations

Peers

David Krause

EPIDE

HEPAT

PHARM

Philipp du Cros United Kingdom

Ioana Bica United States

J. A. J. Barbara United Kingdom

Wasun Chantratita Thailand

Shigui Yang China

Christos Tsoukas Canada

Sean Wasserman South Africa

Paul Dolin United Kingdom

Yuqing Zhou China

Seizaburo Kashiwagi Japan

Philipp du Cros United Kingdom

David Krause

978 ×1.2

EPIDE

1.3k ×1.7

241 ×0.5

HEPAT

108 ×0.5

PHARM

187 ×1.3

Citations per year, relative to David Krause David Krause (= 1×) peers Philipp du Cros

Countries citing papers authored by David Krause

Since Specialization

Citations

This map shows the geographic impact of David Krause's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Krause with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Krause more than expected).

Fields of papers citing papers by David Krause

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Krause. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Krause. The network helps show where David Krause may publish in the future.

Co-authorship network of co-authors of David Krause

This figure shows the co-authorship network connecting the top 25 collaborators of David Krause. A scholar is included among the top collaborators of David Krause based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Krause. David Krause is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Krause, David. (2025). Crypto Security in the Aftermath of the Bybit Hack: Evaluating Risk Management Strategies for Digital Assets. 5(1). 92–101.

Krause, David. (2023). A Primer on Exempt Offerings: Capital Access for Small and Emerging Businesses. SSRN Electronic Journal.

Krause, David. (2023). The Overlooked Growth of Regulation A Crowdfunding Offerings. SSRN Electronic Journal.

Krause, David. (2023). A Literature Review of the Efficacy of Regulation A Following Enactment of the JOBS Act. SSRN Electronic Journal. 1 indexed citations

Binkley, Neil, Henry G. Bone, James P. Gilligan, & David Krause. (2014). Efficacy and safety of oral recombinant calcitonin tablets in postmenopausal women with low bone mass and increased fracture risk: a randomized, placebo-controlled trial. Osteoporosis International. 25(11). 2649–2656. 27 indexed citations

Krause, David, et al.. (2008). CHANGING THE PRESUMPTION OF WHEN TO REGULATE: THE RATIONALE OF CANADIAN TELECOMMUNICATIONS REFORM. Journal of Competition Law & Economics. 4(3). 775–790. 3 indexed citations

Dowell, James A., Martin Stogniew, David Krause, & Bharat Damle. (2007). Anidulafungin Does Not Require Dosage Adjustment in Subjects With Varying Degrees of Hepatic or Renal Impairment. The Journal of Clinical Pharmacology. 47(4). 461–470. 84 indexed citations

Simpson, Lisa, et al.. (2007). Measuring Children's Health Care Quality. American Journal of Medical Quality. 22(2). 80–84. 12 indexed citations

Krause, David & null null. (2006). Overcoming The Challenges of Establishing A Student-Managed Fixed Income Fund. FHSU Scholars Repository (Fort Hays State University). 1 indexed citations

10.

Letson, G. William, Craig N. Shapiro, Thomas K. Welty, et al.. (2004). Effect of maternal antibody on immunogenicity of hepatitis A vaccine in infants. The Journal of Pediatrics. 144(3). 327–332. 52 indexed citations

11.

Dowell, James A., et al.. (2004). Population Pharmacokinetic Analysis of Anidulafungin, an Echinocandin Antifungal. The Journal of Clinical Pharmacology. 44(6). 590–598. 142 indexed citations

12.

Halsey, Neal A., et al.. (1999). Hepatitis B Vaccine Administered to Children and Adolescents at Yearly Intervals. PEDIATRICS. 103(6). 1243–1247. 44 indexed citations

13.

Troisi, Catherine, et al.. (1997). Immunization of seronegative infants with hepatitis A vaccine (HAVRIX®; SKB): a comparative study of two dosing schedules. Vaccine. 15(15). 1613–1617. 42 indexed citations

14.

Goldfarb, Johanna, et al.. (1996). Comparison study of the immunogenicity and safety of 5- and 10- μg dosages of a recombinant hepatitis B vaccine in healthy infants. The Pediatric Infectious Disease Journal. 15(9). 764–767. 14 indexed citations

15.

McMahon, Brian J., James Williams, L. R. Bulkow, et al.. (1995). Immunogenicity Of An Inactivated Hepatitis A Vaccine In Alaska Native Children And Native And Non-Native Adults. The Journal of Infectious Diseases. 171(3). 676–679. 70 indexed citations

16.

DeFraites, Robert F., Brian H. Feighner, Leonard N. Binn, et al.. (1995). Immunization Of Us Soldiers With A Two-Dose Primary Series Of Inactivated Hepatitis A Vaccine: Early Immune Response, Persistence Of Antibody, And Response To A Third Dose At 1 Year. The Journal of Infectious Diseases. 171(Supplement 1). S61–S69. 8 indexed citations

17.

Bernstein, Henry H., Edward Rothstein, Michael E. Pichichero, et al.. (1995). Reactogenicity and immunogenicity of a three-component acellular pertussis vaccine administered as the primary series to 2, 4 and 6 month old infants in the United States. Vaccine. 13(17). 1631–1635. 30 indexed citations

18.

Schoen, Robert T., François Meurice, C. Brunet, et al.. (1995). Safety and Immunogenicity of an Outer Surface Protein A Vaccine in Subjects with Previous Lyme Disease. The Journal of Infectious Diseases. 172(5). 1324–1329. 43 indexed citations

19.

Pass, Robert F., et al.. (1995). Safety And Immunogenicity Of An Inactivated Hepatitis A Vaccine In Preschool Children. The Journal of Infectious Diseases. 171(Supplement 1). S70–S72. 41 indexed citations

20.

Goldfarb, Johanna, Jill E. Baley, Sharon V. Medendorp, et al.. (1994). Comparative study of the immunogenicity and safety of two dosing schedules of Engerix-B hepatitis B vaccine in neonates. The Pediatric Infectious Disease Journal. 13(1). 18–21. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact